Graham Doyle

Stock Analyst at UBS

(2.24)
# 2,732
Out of 5,124 analysts
11
Total ratings
80%
Success rate
6.03%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Sep 2, 2025
Downgrades: Sell
Price Target: n/a
Current: $23.82
Upside: -
GE HealthCare Technologies
May 5, 2025
Upgrades: Neutral
Price Target: $74$73
Current: $82.02
Upside: -11.00%
Smith & Nephew
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $32.81
Upside: -
Koninklijke Philips
Feb 20, 2025
Upgrades: Buy
Price Target: n/a
Current: $27.08
Upside: -